Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

Autor: Virgolini, I. *, Patri, P., Novotny, C., Traub, T., Leimer, M., Füger, B., Li, S.R., Angelberger, P., Raderer, M., Wogritsch, S., Kurtaran, A., Kletter, K., Dudczak, R.
Zdroj: In Annals of Oncology 2001 12 Supplement 2:S41-S45
Databáze: ScienceDirect